Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro

Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2

(2013) Ting-Yu Lin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation

(2013) Sophie Mary et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

StatBite Ovarian Cancer, Five-Year Stage-Specific Relative Survival Rates (2004-2008)

(2011)   JNCI-Journal of the National Cancer Institute

Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

(2009) JD Mitchell et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway

(2009) Knut Ketterer et al.   CANCER LETTERS

Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors

(2008) Richard Einstein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA